Compliance with FDA recommendations for pemoline

J Am Acad Child Adolesc Psychiatry. 2003 Apr;42(4):383; author reply 383. doi: 10.1097/01.CHI.0000037045.04952.A0.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adolescent
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Central Nervous System Stimulants / therapeutic use*
  • Child
  • Child Psychiatry*
  • Guideline Adherence*
  • Humans
  • Pemoline / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Central Nervous System Stimulants
  • Pemoline